Literature DB >> 9145318

Monoclonal antibodies against cathepsin L and procathepsin L of different species.

E Weber1, H Bahn, D Günther.   

Abstract

Mouse monoclonal antibodies directed against cathepsin L and procathepsin L have been generated. Mice were immunized with human procathepsin L purified from the cell culture medium of human nonsmall cell lung cancer cell line EPLC 32 M1. More than 400 hybridoma clones were screened by ELISA or Western blot and 50 were found to secrete antibodies which reacted with cathepsin L or its precursor. Twenty-six clones were selected for further characterization of the antibodies according to their reactivity in ELISA, Western blot, and immunocytochemistry against the mature enzyme or its latent precursor of man, rat, or mouse. Only those antibodies are described here, which do not cross-react with the closely related cathepsins B and S or their latent proenzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145318     DOI: 10.1089/hyb.1997.16.159

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  Diminished intracellular invariant chain expression after vaccinia virus infection.

Authors:  Nan Wang; Ekkehard Weber; Janice S Blum
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

2.  Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Authors:  Eva Tolosa; Weijie Li; Yoshiyuki Yasuda; Wolfgang Wienhold; Lisa K Denzin; Alfred Lautwein; Christoph Driessen; Petra Schnorrer; Ekkehard Weber; Stefan Stevanovic; Raffael Kurek; Arthur Melms; Dieter Bromme
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Pivotal role of cathepsin K in lung fibrosis.

Authors:  Frank Bühling; Christoph Röcken; Frank Brasch; Roland Hartig; Yoshiyuki Yasuda; Paul Saftig; Dieter Brömme; Tobias Welte
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.